Le Lézard
Classified in: Health
Subjects: CALENDAR OF EVENTS, TRADE SHOWS/SEMINARS/WEBINARS

HEXO Corp to participate in Canaccord Genuity 41st Annual Growth Conference


OTTAWA, Aug. 10, 2021 (GLOBE NEWSWIRE) -- HEXO Corp ("HEXO" or the "Company") (TSX: HEXO; NYSE: HEXO) today announced that management will participate in Canaccord Genuity 41st Annual Growth Conference. Sebastien St-Louis, Chief Executive Officer, and Trent MacDonald, Chief Financial Officer, will participate in a presentation today, August 10, 2021 at 1:00 p.m. ET.

Participants may access a live webcast of the presentation by going to the "Events" page on hexocorp.com or by going directly to the Cannacord Webcast. For more information, please contact your Canaccord Genuity representative.

About HEXO Corp (TSX: HEXO; NYSE: HEXO)

HEXO is an award-winning licensed producer of innovative products for the global cannabis market. HEXO serves the Canadian recreational market with a brand portfolio including HEXO, UP Cannabis, Original Stash, Bake Sale, Namaste, and REUP brands, and the medical market in Canada, Israel and Malta. The Company also serves the Colorado market through its Powered by HEXO® strategy and Truss CBD USA, a joint-venture with Molson Coors. In the event that the previously announced transactions to acquire 48North and Redecan close, HEXO expects to be the number one cannabis products company in Canada by recreational market share.

Investor Relations:
[email protected]
 www.hexocorp.com

Media Relations:
(819) 317-0526
[email protected]



These press releases may also interest you

at 14:15
Proposed Illinois College of Osteopathic Medicine at The Chicago School Granted Candidate Status from the Commission on Osteopathic College Accreditation (COCA)
The Chicago School announced that its new proposed Illinois College of Osteopathic Medicine (IllinoisCOM) has been granted Candidate Status from the Commission on Osteopathic College Accreditation (COCA) ? a significant milestone for the institution....

at 14:05
German Federal Patent Court Invalidates Patent Asserted By 10x Genomics, Delivering Legal Win to NanoString and Bruker
Bruker Corporation today announced that the German Federal Patent Court has ruled in favor of NanoString Technologies Germany GmbH by invalidating European Patent No. 2794928B1 (the "928 Patent") in Germany (case 3 Ni 20/22). NanoString is now a...

at 14:05
LEO Pharma Announces Topline Results of Phase 3 Trial in China for Enstilar® (LEO 90100) Demonstrating Superiority in Adult Chinese Subjects With Stable Plaque Psoriasis
GLOBAL RELEASE ? NOT INTENDED FOR DISTRIBUTION IN THE UK LEO Pharma A/S, a global leader in medical dermatology, today announces positive results from the Enstilar® phase 3 trial in China in adult patients living with stable plaque psoriasis. The...

at 14:04
Fzata, Inc. Announces Successful FZ002 Manufacturing and Upcoming Phase 1 Clinical Trial
Fzata, Inc. is pleased to announce successful completion of a current good manufacturing practices (cGMP) run of lead drug, FZ002, with sufficient drug quantities to support the phase 1 first-in-human (FIH) clinical study....

at 14:02
Biotech Leader, BeiGene, Inaugurates Office in Toronto, Canada
BeiGene Canada, the country affiliate of global oncology company BeiGene, specializing in the discovery and development of novel, affordable, and accessible oncology medications, has opened its first office in Canada. Situated in downtown Toronto,...

at 14:00
MemorialCare Cancer Institute Revolutionizes Prostate Cancer Treatment: Hot Water Potential Solution to Prostate Cancer
MemorialCare Cancer Institute at Saddleback Medical Center is the only location in Orange County ? and one of only two in California ? to offer a new, innovative way to treat prostate cancer patients with water vapor. This study, VAPOR 2, utilizes a...

More news about Health...


News published on and distributed by: